Fish-oil drug won't see generic till 2015

04/4/2011 | Reuters

Pronova BioPharma, which makes a fish-oil-derived prescription drug for treating high triglycerides, landed a deal with a generic drugmaker to hold off a copycat drug. Under the agreement, Apotex won't market its generic version of Lovaza until 2015. GlaxoSmithKline, which markets the drug in the U.S., gained $847 million in sales of Lovaza last year.

View Full Article in:


Published in Brief: